Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GD002
- Development stage
- Unknown
- Lead developer
- 3S Guojian Pharmaceutical
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intranasal
01
Overview
GD002 is an investigational exosome-based therapy administered via nasal spray for the treatment of Infantile Epileptic Spasms Syndrome (IESS). Developed by The First Medical Centre of the Chinese PLA General Hospital, GD002 consists of extracellular vesicles designed to deliver therapeutic cargo directly to the central nervous system by bypassing the blood-brain barrier through intranasal instillation. The therapy is currently being evaluated in a clinical trial for pediatric patients who have not responded to standard treatments, including adrenocorticotropic hormone (ACTH) and vigabatrin, with the aim of improving seizure control and neurodevelopmental outcomes through potential neuroprotective and anti-inflammatory mechanisms.
- Other names
- GD002 exosome nasal sprayGD-002 exosome nasal sprayGD 002 exosome nasal spray
Beyond the preview
Go deeper on GD002.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GD002.